Propanc Biopharma (PPCB) Shares Issued (2018 - 2025)

Propanc Biopharma (PPCB) posted quarterly Shares Issued of $0.0 for Q4 2025, little changed quarter-over-quarter from $0.0 in Q3 2025.

Propanc Biopharma (PPCB) Shares Issued (2018 - 2025) Analysis & Trends

Propanc Biopharma (PPCB) has reported Shares Issued for 8 consecutive years, with $0.0 the latest figure, recorded in Q4 2025.

In Q4 2025, Shares Issued changed N/A year-over-year to $0.0; the TTM figure through Dec 2025 stood at $0.0 (changed N/A YoY), while the FY2025 annual figure was $0.0, changed 0.0% from the prior year.
Shares Issued held at $0.0 in Q4 2025 per PPCB's latest filing, from $0.0 in the prior quarter.
Across five years, Shares Issued topped out at $59.0 in Q4 2021 and bottomed at $0.0 in Q2 2023.
Historically, Shares Issued has averaged $20.9 across 5 years, with a median of $0.06 in 2021.
Annual changes were most pronounced in 2022 — Shares Issued soared 180.95% — and 2023, when it plunged 100.0%.
Propanc Biopharma's Shares Issued stood at $59.0 in 2021, then changed by 0.0% to $59.0 in 2022, then plunged by 99.9% to $0.06 in 2023, then slumped by 100.0% to $0.0 in 2024, then changed by 0.0% to $0.0 in 2025.
Business Quant data shows PPCB's Shares Issued at $0.0 in Q4 2025, $0.0 in Q3 2025, and $0.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-
10	Propanc Biopharma	587,855.41	587,855.41	-	0.00

Download Data